Skip to content
OpenCapital
Get started

Microbot Medical MBOT Share-based compensation expense related to employee stock plans

Share-based compensation expense related to employee stock plans at other companies

Intuitive Surgical logo
Intuitive SurgicalISRG
——
Medtronic logo
MedtronicMDT
——

Other financials

Income statement

See full
Revenue$105.0K—
Gross profit$2.0K—
Operating income-$4.3M-43.0%
Net income-$3.7M-41.1%
EPS (diluted)-$0.05+37.5%

Balance sheet

See full
Cash & equivalents$3.7M+13.7%
Total debt$898.0K+551%
Total equity$74.1M+156%
Total assets$78.1M+153%

Cash flow

See full
Operating cash flow-$5.1M-75.8%
CapEx$108.0K+731%
Free cash flow-$5.2M-78.8%

Valuation

See full
Market cap$128.28M+36.1%
Enterprise value$125.53M+39.0%
P/S674.3×—

Profitability

See full
Operating margin25,292.9%—
Net margin-3,669.9%—
FCF margin-852.8%—

Returns & leverage

See full
Return on equity-27.6%-10.2pp
Debt / equity0×0.0×
Current ratio22.6×+6.4×

Where this comes from

Reported directly by Microbot Medical in its filing.

Tagged under the XBRL concept us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue.

The official record: Microbot Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Microbot Medical's share-based compensation expense related to employee stock plans.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Microbot Medical's share-based compensation expense related to employee stock plans?
Microbot Medical (MBOT) reported share-based compensation expense related to employee stock plans of $222K in Q1 2026.
How has Microbot Medical's share-based compensation expense related to employee stock plans changed year-over-year?
Microbot Medical's share-based compensation expense related to employee stock plans decreased by 13.3% year-over-year, from $256K to $222K.
What is the long-term trend for Microbot Medical's share-based compensation expense related to employee stock plans?
Over 4 years (2021 to 2025), Microbot Medical's share-based compensation expense related to employee stock plans has grown at a -6.6% compound annual growth rate (CAGR), from $1.39M to $1.06M.